Gut microbiota and derived metabolomic profiling in glaucoma with progressive neurodegenerationOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined whether alterations in the gut microbiota and their metabolic byproducts are linked to glaucoma, a neurodegenerative eye disease marked by progressive loss of retinal ganglion cells (RGCs). Researchers used 16S rRNA (V1-V9 region) sequencing to profile cecal bacterial communities and untargeted metabolomics to characterize circulating metabolites. They then examined how microbial composition and metabolite levels related to RGC status. The overall aim was to determine whether gut-derived signals interact with the neurodegenerative process occurring in glaucoma.
Who was studied?
The study population was a glaucomatous rat model compared against a control group of rats, rather than a human cohort. Cecal bacterial samples and metabolomic profiles were obtained from these two groups of animals. Specific numbers of animals per group are not stated in the abstract, so no sample size can be reported beyond the two-group comparison.
What were the most important findings?
Glaucomatous rats showed markedly reduced diversity of cecal bacteria compared with controls, along with a significantly different overall microbial composition. The Firmicutes/Bacteroidetes ratio, the phylum Verrucomicrobia, and the genera Romboutsia, Akkermansia, and Bacteroides were all substantially elevated in glaucomatous animals, and each of these showed a negative correlation with RGC measures. Untargeted metabolomic analysis identified 284 differentially expressed metabolites, with pathway enrichment analysis pointing strongly to alterations in bile secretion pathways.
What are the greatest implications of this study?
The findings suggest that gut microbial dysbiosis and disrupted bile-acid-related metabolism may be mechanistically connected to retinal ganglion cell loss in glaucoma. Because several dysbiosis markers correlated negatively with RGC status, the gut-retina axis may represent a contributing factor in glaucoma progression rather than a bystander phenomenon. These results position the gut microbiota and its bile secretion-related metabolites as potential targets for further mechanistic investigation in neurodegenerative eye disease.